The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makoveev S.A.

Northern State Medical University;
Arkhangelsk Regional Clinical Hospital

Semenkova T.N.

Northern State Medical University;
Volosevich First City Clinical Hospital

Lochekhina E.B.

Northern State Medical University;
Severodvinsk City Clinical Hospital No. 2

Hussain A.

Northern State Medical University;
Volosevich First City Clinical Hospital

Kirov M.Yu.

Northern State Medical University

The relationship of hypothermia and organ dysfunction in sepsis: a single-center retrospective study

Authors:

Makoveev S.A., Semenkova T.N., Lochekhina E.B., Hussain A., Kirov M.Yu.

More about the authors

Read: 4267 times


To cite this article:

Makoveev SA, Semenkova TN, Lochekhina EB, Hussain A, Kirov MYu. The relationship of hypothermia and organ dysfunction in sepsis: a single-center retrospective study. Russian Journal of Anesthesiology and Reanimatology. 2022;(4):26‑31. (In Russ., In Engl.)
https://doi.org/10.17116/anaesthesiology202204126

Recommended articles:
Neurometabolic therapy with Cere­brolysin in patients with sepsis-associated ence­phalopathy. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):46-54
Nutritional support for sepsis: is there a single concept?. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):70-78
The role of neutrophils in the mechanisms of sepsis. Russian Journal of Archive of Pathology. 2024;(6):82-91
Septic complications after abdo­minal deli­very (literature review). Russian Journal of Human Reproduction. 2024;(6):108-117
Asce­nding aorta and aortic arch replacement without circulatory arrest. Piro­gov Russian Journal of Surgery. 2025;(2):119-122
Inadvertent perioperative hypo­thermia in plastic surgery. Plastic Surgery and Aesthetic Medi­cine. 2025;(1):5-13
Prediction and prevention of inadvertent perioperative hypo­thermia in plastic surgery. Plastic Surgery and Aesthetic Medi­cine. 2025;(2):76-82
Prognostic model of a patient with sepsis readiness to early mobi­lization with assi­stance. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):26-26

Introduction

Sepsis is an important public health and critical care problem worldwide. Despite a significant progress in understanding the mechanisms underlying sepsis, mortality in these patients is still high, and sepsis per se is the main cause of adverse outcomes in intensive care units (ICU) [1-3]. In this regard, searching for prognostic criteria of unfavorable course of disease is an actual scientific problem.

Body temperature is an obligatory physiological constant, and its maintaining within a certain range is essential for adequate functioning of human organs and systems. Even small deviations in body temperature can lead to significant metabolic changes [4]. Temperature imbalances are common in patients with systemic inflammation and often accompany sepsis and septic shock. Hyperthermia (central body temperature > 38°C) is due to the effect of pyrogens. It is a generally recognized manifestation of infectious diseases [5]. However, some observational studies revealed hypothermia (body temperature < 36 °C) in 35% of patients with sepsis [6].

It is known that unintentional hypothermia can be complicated by dysfunction of cardiovascular system, central nervous system, blood coagulation system and other ones [7, 8]. Hypothermia in patients with sepsis may be associated with immune suppression, hypodynamic shock and some other manifestations. Nevertheless, the effect of temperature imbalances on the course and outcomes of sepsis is still a matter of debate [9–11].

The causes of hypothermic reaction in patients with sepsis also raise certain questions. Analysis of cytokines as main mediators of hyperthermia showed that suppression of pro-inflammatory reaction following sepsis is not always accompanied by body temperature decrease [12, 13]. Importantly, damage to endothelial glycocalyx may be essential in hypothermia following sepsis. Indeed, this event contributes to vascular tone decrease, leads to heat loss and prevents the body's ability to regulate central temperature [13, 14].

The objective was to assess the relationship of body temperature disorders with organ dysfunction and outcomes in patients with sepsis.

Material and methods

A single-center retrospective study enrolled data of 353 ICU patients admitted to the Volosevich Clinical Hospital between 2018 and 2020. Inclusion criterion was signs of sepsis upon admission to ICU according to Sepsis-3 definition, i.e. focal infection combined with organ dysfunction (SOFA score increase by more than 2 points compared to baseline values). We collected biometric data, indicators of clinical severity and severity of organ dysfunction, including diagnosis, surgical intervention before admission to ICU, ICU-stay, mortality, SOFA score upon admission, special methods of treatment (mechanical ventilation, inotropic / vasopressor support), body temperature, hemodynamic parameters and laboratory data (pH, serum glucose, lactate, hemoglobin, bilirubin, creatinine, white blood cell count, platelet count, international normalized ratio (INR)).

We analyzed data upon admission to ICU, 12 and 24 hours later. Additionally, blood sampling and evaluation of endothelial glycocalyx (EG) components were carried out in 21 patients (heparan sulfate proteoglycan (HSPG) and syndecan 1 (S1)). EG components were assessed by using of enzyme immunoassay (ELISA Kit for HSPG, SDC 1, USA). Data were recorded at the beginning of the study, after 2 and 24 hours.

Statistical analysis was performed using the SPSS software package version 21.0 (SPSS Inc., USA). Data distribution normality was tested using the Shapiro–Wilk test. Data are presented as mean and standard deviation or median (25th-75th percentile) depending on distribution. Statistical analysis was performed using parametric and non-parametric tests (Student's t-test and Mann-Whitney test). The χ2 test was used to analyze qualitative features. Repeated measure data were assessed by variance analysis for repeated measures followed by contrast test or Friedman's test depending on distribution. Spearman's correlation analysis with rho coefficient was used to identify data correlation. For all tests, p<0.05 was considered significant.

Results

A total of 6304 ICU cards were analyzed. The study included 353 ones with sepsis who accounted for 5.6% of all ICU patients. Demographic data, mean age and length of ICU-stay are presented in Table 1.

Table 1. Characteristics of patients with sepsis

Variable

Patients (n=353)

Male, n (%)

191 (54.1)

Female, n (%)

162 (45.9)

ICU-stay, days

3 (2—6)

Overall mortality, n (%)

150 (42.5)

Cause of sepsis, n (%)

Pulmonary infection

115 (32.6)

Abdominal infection

141 (39.9)

Urological infection

40 (11.3)

Skin and soft tissue infection

27 (7.6)

Vascular infections

15 (4.2)

CNS infections

9 (2.5)

Other infections

5 (1.7)

Note. CNS — central nervous system; ICU — intensive care unit.

When ranking by temperature, we found that 82 (23.2%) patients admitted with hypothermia (<36°C), 254 (72.0%) patients with normal/subfebrile body temperature (36-38°C) and 17 (4.8%) patients with febrile temperature (over 38°C). Among all ICU patients, 173 (49%) ones admitted after previous surgery. Surgery was performed in 52 (63%) patients with hypothermia. There were 30 (37%) therapeutic patients with hypothermia.

Hemodynamic parameters and laboratory data depending on baseline body temperature are presented in Table 2. Vasopressor support and low mean arterial pressure (MAP) were more common in patients with hypothermia upon admission to ICU and after 24 hours compared to patients with normal and elevated body temperature. Moreover, hypothermia was followed by more severe acidosis. Correlation analysis revealed the relationship between body temperature and pH upon admission to ICU (rho =0.304, p<0.001). There were no significant between-group differences in SOFA scores, serum glucose, bilirubin, creatinine, platelet count and INR.

Table 2. Characteristics of patients depending on body temperature

Variable

Hypothermia

Normal/febrile temperature

p-value

Body temperature upon admission, °C

35.6 (35.0—35.7)

36.5 (36.1—37.0)

<0.001

Vasopressor support, n (%)

57 (70.4)

156 (57.6)

0.039

MAP upon admission, mm Hg

77 (60—90)

82 (67—98)

0.023

MAP after 12 hours, mm Hg

78 (70—88)

81 (72—90)

0.177

MAP after 24 hours, mm Hg

77 (70—90)

83 (73—93)

0.03

pH upon admission

7.21 (7.12—7.34)

7.34 (7.23—7.41)

<0.001

Lactate upon admission, mmol/l

4.0 (1.7—8.4)

3.1 (1.7—6.4)

0.19

WBC count upon admission, × 109/L

12.7 (6.7—20.4)

13.0 (7.8—19.7)

0.54

Mortality, n (%)

39 (48)

111 (40)

0.445

Note. MAP — mean arterial pressure. WBC — white blood cell.

Subgroup of therapeutic patients

Hemodynamic parameters and laboratory data of therapeutic patients depending on baseline body temperature are presented in Table 3. Patients with hypothermia upon admission to ICU and no need for surgery had lower MAP, more severe metabolic lactic acidosis, INR increase and lower serum glucose. Moreover, therapeutic patients with hypothermia following sepsis were characterized by higher mortality rate (53.3% compared to 31.5% in patients with normal and febrile body temperature).

Table 3. Characteristics of therapeutic patients with sepsis depending on body temperature

Variable

Hypothermia

Normal/febrile temperature

p-value

Body temperature upon admission, °C

35.5 (35.0—35.7)

36.7 (36.3—37.3)

<0.001

Vasopressor support, n (%)

20 (66.7)

69 (47.63)

0.041

MAP upon admission, mm Hg

65 (54—89)

82 (70—98)

0.022

MAP after 12 hours, mm Hg

76 (70—83)

83 (70—91)

0.079

MAP after 24 hours, mm Hg

75 (65—79)

83 (70—91)

0.012

pH upon admission

7.23 (7.11—7.4)

7.35 (7.233—7.43)

0.017

Lactate in 12 hours after admission, mmol/l

2.7 (1.8—5.9)

2.4 (1.5—4.1)

0.03

INR in 24 hours after admission

1.7 (1.3—2.2)

1.3 (1.1—1.6)

0.03

Serum glucose in 24 hours after admission, mmol/l

6.6 (4.6—10.3)

7.8 (6.2—10.3)

0.023

Mortality, n (%)

16 (53.3)

46 (31.5)

0.023

Note. MAP — mean arterial pressure; INR — international normalized ratio.

There were no between-group differences in SOFA score, WBC and platelet count, serum bilirubin and creatinine levels. Correlation analysis of therapeutic patients revealed a relationship between body temperature and pH upon admission to ICU (rho=0.328, p<0.001), as well as between body temperature and MAP (rho=0.231, p<0.002).

Indicators of endothelial glycocalyx components

Parameters of EG components were analyzed in 8 patients with hypothermia and 13 patients with normothermia/febrile temperature. Concentrations of S1 and HSPG within 2 hours are presented in Table 4. It is noteworthy that patients with hypothermia had higher serum S1 at all stages of the study compared to those with normal or febrile body temperature. At the same time, we found increment of serum S1 by 20% within 2 hours of ICU-stay in patients with hypothermia (p<0.001). After 24 hours, serum S1 concentrations were similar to baseline values in patients with hypothermia. There were no significant between-group differences in HSPG concentration.

Table 4. Changes of endothelial glycocalyx components in hypothermic and normothermic/febrile patients with sepsis

Variable

Hypothermia

Normal/febrile temperature

p-value

S1 upon admission, ng/ml

2.55 (1.15—3.29)

0.91 (0.70—1.88)

0.010

S1 in 2 hours after admission, ng/ml

3.06 (1.75—7.01)

0.94 (0.57—1.31)

0.003

S1 in 24 hours after admission, ng/ml

2.23 (1.44—2.95)

0.74 (0.46—0.95)

0.003

HSPG upon admission, ng/ml

2.94 (2.17—5.16)

2.56 (1.48—7.42)

0.800

HSPG in 2 hours after admission, ng/ml

3.26 (1.93—7.59)

3.00 (1.79—5.62)

0.657

HSPG in 24 hours after admission, ng/ml

2.15 (1.70—4.13)

1.58 (1.40—6.95)

0.711

Note. S1 — syndecan-1; HSPG — heparan sulfate proteoglycan.

Discussion

According to our data, hypothermia in ICU patients with sepsis is accompanied by more severe hemodynamic disorders and acidosis. Moreover, hypothermia is associated with impaired tissue perfusion and coagulation abnormalities, as well as unfavorable outcomes in therapeutic patients. Patients with hypothermia had certain concomitant syndromes, mainly due to pulmonary, abdominal and urological infections, which could affect the course and outcomes of disease. Other authors reported similar results [10, 15–17].

The majority of patients (95.2%) admitted to ICU with normal body temperature or hypothermia. Considering that 49% of patients admitted after surgery, we can assume that some patients developed unintentional hypothermia due to insufficient intraoperative temperature control. According to literature data, intraoperative body temperature control is still an important problem requiring changes in approaches to thermometry and treatment of hypothermia in ICU patients with a wider use of hardware monitoring, including nasopharyngeal and esophageal sensors, as well as devices for warming in perioperative period [18, 19].

Lower body temperature in patients with sepsis was associated with more severe arterial hypotension. These changes were accompanied by metabolic acidosis that is confirmed by direct correlation between body temperature and pH upon admission to ICU. More common hemodynamic disturbances in patients with hypothermia required inotropic/vasopressor support that is consistent with the results obtained by other authors [15, 18, 19]. At the same time, mortality was similar in both groups.

Hypothermia may be unintentional in postoperative patients [20]. Therefore, we additionally analyzed therapeutic patients with sepsis. Analyzing hemodynamic parameters and laboratory data upon admission to ICU in these patients, we found a direct correlation between severity of hypothermia and arterial hypotension. In addition, hypothermia associated with non-surgical sepsis was accompanied by significant metabolic disturbances including lactic acidosis and higher INR. These disorders characterize severity of organ dysfunction that indicates the need for more comprehensive approach to treatment of these patients in addition to maintaining normothermia [10, 20]. It is noteworthy that we observed a lower severity of hyperglycemia in therapeutic patients with hypothermia and sepsis. This phenomenon can be explained by adrenal insufficiency. The last one is common in patients with sepsis and septic shock and accompanied by hypotension, hypoglycemia, electrolyte disorders and hypothermia [21, 22].

Mortality rate in therapeutic patients with sepsis and hypothermia is 53.3% that is similar to previous data [23–25]. This value significantly exceeds mortality rate in patients with normal and febrile body temperature. This is consistent with the data of experimental studies, which also showed that fever associated with infectious diseases can be a sign of physiological reaction. Indeed, fever increases the effectiveness of antibiotics and improves function of immune cells via suppression of replication of bacteria and viruses [26]. These data indicate the need for timely screening for organ dysfunction and early personalized therapy in patients with hypothermia and sepsis.

Endotheliopathy is the key mechanism of sepsis-associated multiple organ failure. We found that hypothermia was accompanied by higher level of S1 at all stages of the study. Wiewel M.A. et al. [13] also reported the relationship between hypothermia and characteristics of glycocalyx components in patients with sepsis. The authors emphasized that hypothermia following infectious process is associated with release of endothelial damage marker (fractalkine). Probably, endothelial damage and vasodilation are among the factors disrupting thermoregulation in sepsis and leading to hypothermia. Nevertheless, additional prospective studies are required to assess the role of endothelium in temperature imbalance in patients with sepsis.

Conclusion

Hypothermia upon admission to intensive care unit can be a predictor of unfavorable course of disease and outcomes in patients with sepsis. This is especially true for therapeutic patients. Hypothermia following sepsis is accompanied by more severe shock and acidosis, as well as endotheliopathy and coagulopathy. Further studies of functional role of endothelial glycocalyx in hypothermia are needed.

The authors declare no conflicts of interest.

References:

  1. Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level. Critical Care Medicine. 2018;46(12):1889-1897. https://doi.org/10.1097/CCM.0000000000003342
  2. Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019 — results from a systematic review and meta-analysis. Critical Care. 2020;24(1):239.  https://doi.org/10.1186/s13054-020-02950-2
  3. Chiu C, Legrand M. Epidemiology of sepsis and septic shock. Current Opinion in Anaesthesiology. 2021;34(2):71-76.  https://doi.org/10.1097/ACO.0000000000000958
  4. Petrone P, Kuncir EJ, Asensio JA. Surgical management and strategies in the treatment of hypothermia and cold injury. Emergency Medicine Clinics of North America. 2003;21(4):1165-1178. https://doi.org/10.1016/s0733-8627(03)00074-9
  5. Walter EJ, Hanna-Jumma S, Carraretto M, Forni L. The pathophysiological basis and consequences of fever. Critical Care. 2016;20(1):200.  https://doi.org/10.1186/s13054-016-1375-5
  6. Kushimoto S, Gando S, Saitoh D, Mayumi T, Ogura H, Fujishima S, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N; JAAM Sepsis Registry Study Group. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Critical Care. 2013;17(6):R271. https://doi.org/10.1186/cc13106
  7. Konnov DYu, Konnova TYu, Lukyanov SA, Shapovalov KK. Changes in Heart Rhythm and Breathing in Acute Systemic Injury Due to Cold. Obshchaya reanimatologiya. 2015;11(3):16-23. (In Russ.). https://doi.org/10.15360/1813-9779-2015-3-16-23
  8. Mustafa S, Shaikh N, Gowda RM, Khan IA. Electrocardiographic features of hypothermia. Cardiology. 2005;103(3):118-119.  https://doi.org/10.1159/000083434
  9. Broman ME, Vincent J-L, Ronco C, Hansson F, Bell M. The Relationship between Heart Rate and Body Temperature in Critically Ill Patients. Critical Care Medicine. 2021;49(3):327-331.  https://doi.org/10.1097/CCM.0000000000004807
  10. Kushimoto S, Abe T, Ogura H, Shiraishi A, Saitoh D, Fujishima S, Mayumi T, Hifumi T, Shiino Y, Nakada TA, Tarui T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Yamakawa K, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S; JAAM Focused Outcome Research on Emergency Care for Acute respiratory distress syndrome, Sepsis and Trauma (FORECAST) Group. Impact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients with Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis and Trauma Study. Critical Care Medicine. 2019;47(5):691-699.  https://doi.org/10.1097/CCM.0000000000003688
  11. Drewry AM, Fuller BM, Skrupky LP, Hotchkiss RS. The presence of hypothermia within 24 hours of sepsis diagnosis predicts persistent lymphopenia. Critical Care Medicine. 2015;43(6):1165-1169. https://doi.org/10.1097/CCM.0000000000000940
  12. Marik PE, Zaloga GP. Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. Intensive Care Medicine. 2000;26(6):716-721.  https://doi.org/10.1007/s001340051237
  13. Wiewel MA, Harmon MB, van Vught LA, Scicluna BP, Hoogendijk AJ, Horn J, Zwinderman AH, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T, Juffermans NP, Wiersinga WJ. Risk factors, host response and outcome of hypothermic sepsis. Critical Care. 2016;20(1):328.  https://doi.org/10.1186/s13054-016-1510-3
  14. Il’ina YaYu, Fot EV, Kuz’kov VV, Kirov MYu. Sepsis-induced endothelial glycocalyx damage (literature review). Vestnik intensivnoῐ terapii imeni A.I. Saltanova. 2019;2:32-39. (In Russ.). https://doi.org/10.21320/1818-474X-2019-2-32-39
  15. Danzl DF, Pozos RS, Auerbach PS, Glazer S, Goetz W, Johnson E, Jui J, Lilja P, Marx JA, Miller J. Annals of Emergency Medicine. 1987;16(9):1042-1055. https://doi.org/10.1016/s0196-0644(87)80757-6
  16. Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, Finfer S, Harrison D, Myburgh J, Rowan K. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Medicine [published online ahead of print, 2012 Jan 31]. https://doi.org/10.1007/s00134-012-2478-3
  17. Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Critical Care (London, England). 2012;16(1):R33.  https://doi.org/10.1186/cc11211
  18. Yi J, Lei Y, Xu S, Si Y, Li S, Xia Z, Shi Y, Gu X, Yu J, Xu G, Gu E, Yu Y, Chen Y, Jia H, Wang Y, Wang X, Chai X, Jin X, Chen J, Xu M, Xiong J, Wang G, Lu K, Yu W, Lei W, Qin Z, Xiang J, Li L, Xiang Z, Pan S, Zhan L, Qiu K, Yao M, Huang Y. Intraoperative hypothermia and its clinical outcomes in patients undergoing general anesthesia: National study in China. PloS One. 2017;12(6):e0177221. https://doi.org/10.1371/journal.pone.0177221
  19. Van der Ploeg G-J, Goslings JC, Walpoth BH, Bierens JJLM. Accidental hypothermia: rewarming treatments, complications and outcomes from one university medical centre. Resuscitation. 2010;81(11):1550-1555. https://doi.org/10.1016/j.resuscitation.2010.05.023
  20. Makoveev SA, Hussejn A, Perembetov NV, Hlopushin AV, Eremeev AV, Procenko DN, Celyh NV, Shapovalov KG, Emel’yanov RS, Bayalieva AZh, Zabolotskih IB, Shchegolev AV, Potapov AF, Matveev AS, Kirov MYu. Incidence, structure and outcomes of hypothermia in adult patients admitting to intensive care unit: a multiple-center retrospective study. Anesteziologiya i reanimatologiya. 2019;4:31-37. (In Russ.). https://doi.org/10.17116/anaesthesiology201904131
  21. Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, Marik PE, Umberto Meduri G, Olsen KM, Rodgers SC, Russell JA, Van den Berghe G. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Critical Care Medicine. 2017;45(12):2078-2088. https://doi.org/10.1097/CCM.0000000000002737
  22. Cooper MS, Stewart PM. Corticosteroid Insufficiency in Acutely Ill Patients. The New England Journal of Medicine. 2003;348(8):727-734.  https://doi.org/10.1056/NEJMra020529
  23. Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF. Determinants of temperature abnormalities and influence on outcome of critical illness. Critical Care Medicine. 2012;40(1):145-151.  https://doi.org/10.1097/CCM.0b013e31822f061d
  24. Tiruvoipati R, Ong K, Gangopadhyay H, Arora S, Carney I, Botha J. Hypothermia predicts mortality in critically ill elderly patients with sepsis. BMC Geriatrics. 2010;10:70.  https://doi.org/10.1186/1471-2318-10-70
  25. Peres Bota D, Lopes Ferreira F, Mélot C, Vincent JL. Body temperature alterations in the critically ill. Intensive Care Medicine. 2004;30(5):811-816.  https://doi.org/10.1007/s00134-004-2166-z
  26. Dias A, Gomez VC, Viola LR, Rodrigues ACP, Weber SP, Tartaro L, da Silva Marques L, Boniatti MM. Fever is associated with earlier antibiotic onset and reduced mortality in patients with sepsis admitted to the ICU. Scientific Reports. 2021;11(1):23949. https://doi.org/10.1038/s41598-021-03296-7
  • Palmer BF, Clegg DJ. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018;378(2):203-204.  https://doi.org/10.1056/NEJMc1714331
  • Broeren MA, Geerdink EA, Vader HL, van den Wall Bake AW. Hypomagnesemia induced by several proton-pump inhibitors [published correction appears in Ann Intern Med. 2010;152(4):268]. Ann Intern Med. 2009;151(10):755-756.  https://doi.org/10.7326/0003-4819-151-10-200911170-00016
  • Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One. 2014;9(11):e112558. Published 2014 Nov 13.  https://doi.org/10.1371/journal.pone.0112558
  • Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail. 2015;37(7):1237-1241. https://doi.org/10.3109/0886022X.2015.1057800
  • FDA drug safety communication: low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). Silver Spring, MD: Food and Drug Administration, March 2, 2011. https://www.fda.gov/drugs/drugsafety/ucm245011.htm
  • Palmer BF. Diagnostic approach and management of inpatient hyponatremia. J Hosp Med. 2010;5(suppl 3):1-7.  https://doi.org/10.1002/jhm.702
  • Achinger SG, Ayus JC. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018;378(2):202-203.  https://doi.org/10.1056/NEJMc1714331
  • Sterns RH, Silver SM. Complications and management of hyponatremia. Curr Opin Nephrol Hypertens. 2016;25(2):114-119.  https://doi.org/10.1097/MNH.0000000000000200
  • Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis. 2007;50(4):673-680.  https://doi.org/10.1053/j.ajkd.2007.07.015
  • Bähr M, Sommer N, Petersen D, Wiethölter H, Dichgans J. Central pontine myelinolysis associated with low potassium levels in alcoholism. J Neurol. 1990;237(4):275-276.  https://doi.org/10.1007/BF00314635
  • Falcone N, Compagnoni A, Meschini C, Perrone C, Nappo A. Central pontine myelinolysis induced by hypophosphatemia following Wernicke’s encephalopathy. Neurol Sci. 2004;24(6):407-410.  https://doi.org/10.1007/s10072-003-0197-9
  • Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69(8):1319-1325. https://doi.org/10.1038/sj.ki.5000187
  • Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med. 2015;372(1):55-65.  https://doi.org/10.1056/NEJMra1404489
  • Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.